Related Experiment Video

Updated: May 29, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Transforming growth factor-β-stimulated clone-22 is a negative-feedback regulator of Ras / Raf signaling:

Masaki Nakamura1, Jiro Kitaura, Yutaka Enomoto

  • 1Division of Cellular Therapy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.

Cancer Science
|September 28, 2011
PubMed

Insights

Transforming growth factor-β (TGF-β)-stimulated clone-22 (TSC-22) acts as a tumor suppressor by inhibiting Ras/Raf signaling. Upregulation and nuclear translocation of TSC-22 are key to this feedback suppression, impacting tumorigenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Signal Transduction

Background:

  • Transforming growth factor-β (TGF-β)-stimulated clone-22 (TSC-22), also known as TSC22D1-2, is a potential tumor suppressor.
  • TSC-22 was previously identified downstream of an active mutant of fms-like tyrosine kinase-3 (Flt3).

Purpose of the Study:

  • To elucidate the mechanism by which TSC-22 functions as a tumor suppressor.
  • To investigate the role of TSC-22 in regulating Ras/Raf signaling pathways.

Main Methods:

  • Investigated TSC-22 expression and localization in response to Ras/Raf and STAT5 activation.
  • Utilized NIH3T3 cells expressing oncogenic H-Ras and TSC22D1-deficient mice models.
  • Examined TSC-22's interaction with Ras/Raf signaling components and its functional impact on cell transformation and tumorigenesis.

Main Results:

  • TSC-22 suppresses tumor growth, transformation, and tumorigenesis by inhibiting Ras/Raf signaling.
  • Ras/Raf activation leads to TSC-22 upregulation and nuclear translocation, mediated by its nuclear export signal (NES).
  • TSC22D1-deficient mice showed increased susceptibility to chemically-induced liver tumors with active Ras/Raf mutations.

Conclusions:

  • TSC-22 acts as a novel suppressor of oncogenic Ras/Raf-induced tumors through a mechanism distinct from GILZ.
  • Upregulation and nuclear translocation of TSC-22 are crucial for the feedback suppression of Ras/Raf signaling.
  • These findings highlight TSC-22 as a potential therapeutic target in cancers driven by Ras/Raf mutations.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...